Beta Drugs Limited — Cisplatin Exporter Profile
Indian Pharmaceutical Exporter · #12 for Cisplatin · $180.9K export value · DGFT Verified
Beta Drugs Limited is the #12 Indian exporter of Cisplatin with $180.9K in export value and 56 verified shipments. Beta Drugs Limited holds a 1.4% market share in Cisplatin exports across 12 countries. The company exports 17 pharmaceutical products worth $7.8M across 5 therapeutic categories.
Beta Drugs Limited — Cisplatin Export Profile: Buyers & Destinations
Where Does Beta Drugs Limited Export Cisplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $71.1K | 13 | 39.3% |
| MOZAMBIQUE | $25.3K | 2 | 14.0% |
| NEPAL | $22.1K | 14 | 12.2% |
| MYANMAR | $15.6K | 3 | 8.6% |
| ZAMBIA | $15.0K | 2 | 8.3% |
| KENYA | $14.8K | 4 | 8.2% |
| VENEZUELA | $6.0K | 4 | 3.3% |
| RWANDA | $6.0K | 4 | 3.3% |
| UNITED KINGDOM | $2.6K | 1 | 1.4% |
| AFGHANISTAN | $2.2K | 2 | 1.2% |
Beta Drugs Limited exports Cisplatin to 12 countries. The largest destination is ETHIOPIA accounting for 39.3% of Beta Drugs Limited's Cisplatin shipments, followed by MOZAMBIQUE (14.0%) and NEPAL (12.2%). These destinations reflect Beta Drugs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cisplatin from Beta Drugs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | KENYA | $75.4K | 18 |
| GENRICS AND SPECIALITIES LIMITADA | MOZAMBIQUE | $25.3K | 2 |
| AUGUSTA LIMITED | ZAMBIA | $15.0K | 2 |
| DIRECTORATE OF PROCUREMENT | MYANMAR | $12.5K | 1 |
| SIJAL PHARMA PVT LTD | NEPAL | $10.2K | 9 |
| GALAXY PHARMACEUTICAL LTD | KENYA | $6.9K | 1 |
| SIJAL PHARMA PRIVATE LIMITED | NEPAL | $5.8K | 1 |
| ADEBABAY KASAW (FIDEL PHARMACEUTICA | ETHIOPIA | $5.0K | 1 |
| TO THE ORDER | KENYA | $4.8K | 1 |
| GLOBAL CARE PHARMA,CA | VENEZUELA | $3.2K | 1 |
Beta Drugs Limited supplies Cisplatin to 22 buyers globally. The largest buyer is TO THE ORDER OF (KENYA), followed by GENRICS AND SPECIALITIES LIMITADA (MOZAMBIQUE) and AUGUSTA LIMITED (ZAMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cisplatin Export Value and How Much Does Beta Drugs Limited Contribute?
India exported $9.6M worth of Cisplatin through 1,701 shipments from 233 suppliers to 130 countries, serving 584 buyers globally. Beta Drugs Limited contributes $180.9K to this total, accounting for 1.4% of India's Cisplatin exports. Beta Drugs Limited ships Cisplatin to 12 countries through 22 buyers.
What Is the Average Shipment Value for Beta Drugs Limited's Cisplatin Exports?
Beta Drugs Limited's average Cisplatin shipment value is $3.2K per consignment, based on 56 shipments totaling $180.9K. The largest destination is ETHIOPIA (39.3% of Beta Drugs Limited's Cisplatin exports).
How Does Beta Drugs Limited Compare to Other Indian Cisplatin Exporters?
Beta Drugs Limited ranks #12 among 233 Indian Cisplatin exporters with a 1.4% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($2.8M), VENUS REMEDIES LIMITED ($1.7M), INTAS PHARMACEUTICALS LIMITED ($1.5M). Beta Drugs Limited processed 56 shipments to 12 destination countries.
What Cisplatin Formulations Does Beta Drugs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ADCIST-50 MG (CISPLATIN 50MG) ,BATCH : B | $25.3K | 2 |
| ADCIST 50 MG CISPLATIN INJECTION BP ( 50MG/50 ML) BATCH: BCII2503XB, MFD: FEB-25, EXP: JAN-27 | $22.4K | 6 |
| ADCIST 50MG CISPLATIN INJECTION BP 50MG 50ML BATCH NO ADC2215CI MFD 01 2023 EXP 12 2024 | $12.5K | 1 |
| ADCIST 50 MG CISPLATIN INJECTION BP (50MG/50 ML) BATCH: BCII2435XA, MFD: DEC-24, EXP: NOV-26 | $12.4K | 1 |
| ADCIST 50 MG CISPLATIN INJECTION BP (50MG/50 ML) BATCH: BCII2436XA, MFD: DEC-24, EXP: NOV-26 | $12.4K | 1 |
| ADCIST 50 MG CISPLATIN INJECTION IP 50MG/50ML BATCH: BCII2329XA MFD: NOV-23 EXP: OCT-25 | $11.9K | 1 |
| ADCIST 50 MG CISPLATIN INJECTION BP (50MG/50 ML) BATCH: BCII2437XA, MFD: DEC-24, EXP: NOV-26 | $10.8K | 1 |
| ADCIST 50 MG CISPLATIN INJECTION BP 50MG 50ML BATCH BCII2506XA MFD APR 25 EXP MAR 27 | $6.9K | 1 |
| ADCIST 50MG CISPLATIN INJECTION IP 50 MG/50ML BATCH:BCII2328XA MFD: OCT-23 EXP: SEP-25 | $5.8K | 1 |
| ADCIST 50 MG CISPLATIN INJECTION (50 MG/ 50 ML) BATCH: BCII2502XA, MFD: JAN-25,EXP: DEC-26 | $5.0K | 1 |
Beta Drugs Limited exports 42 distinct Cisplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ADCIST-50 MG (CISPLATIN 50MG) ,BATCH : B with 2 shipments worth $25.3K.
How Does Beta Drugs Limited Compare to Nearest Cisplatin Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | MEDORBIS TRADE LLP | $208.8K | 11 | 2 | $19.0K |
| 4 | NV REMEDIES PRIVATE LIMITED | $200.0K | 4 | 1 | $50.0K |
| 12 | BETA DRUGS LIMITED ★ | $180.9K | 56 | 12 | $3.2K |
| 13 | VHB MEDI SCIENCES LIMITED | $174.3K | 16 | 6 | $10.9K |
| 14 | PRIME PHARMACEUTICALS PRIVATE LIMITED | $150.0K | 3 | 1 | $50.0K |
Beta Drugs Limited ranks #12 among 233 Indian Cisplatin exporters. Average shipment value of $3.2K compared to the market average of $41.2K. The closest competitors by value are MEDORBIS TRADE LLP and NV REMEDIES PRIVATE LIMITED.
Which Indian Ports Ship Cisplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 300 | 17.6% |
| SAHAR AIR | 281 | 16.5% |
| DELHI AIR CARGO ACC (INDEL4) | 260 | 15.3% |
| DELHI AIR | 237 | 13.9% |
| Bombay Air | 104 | 6.1% |
| Delhi Air | 53 | 3.1% |
| Delhi Air Cargo | 37 | 2.2% |
| HYDERABAD ACC (INHYD4) | 35 | 2.1% |
What Other Oncology Products Does Beta Drugs Limited Export?
Beta Drugs Limited also exports these oncology products. Each links to the detailed product page.
About Beta Drugs Limited
Beta Drugs Limited exports 17 products worth $7.8M. Beyond Cisplatin, top products include Linagliptin, Sitagliptin, Carboplatin, Capecitabine, Mercaptopurine. View the complete Beta Drugs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cisplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cisplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Beta Drugs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 56 individual customs records matching Beta Drugs Limited exporting Cisplatin, covering 42 formulations to 12 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 130+ countries, 584+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cisplatin Export Data from Beta Drugs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Beta Drugs Limited's Cisplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Beta Drugs Limited
Full Company Profile →
17 products · $7.8M total trade · 5 categories
Cisplatin Stats
Company Overview
Top Products by Beta Drugs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Beta Drugs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cisplatin. For current shipment-level data, contact TransData Nexus.